Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB26FWUSC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,874
Award facts
- Contract value 100% obligated
- $25,874.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,874.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. The award was issued on November 7, 2025, with an ultimate completion date of December 2, 2025, under a firm fixed-price contract structure with no set-aside designation. This delivery order is issued against DMS Pharmaceutical Group's single-award Indefinite Delivery Contract under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to streamline pharmaceutical supply chains for Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial capability as a critical pharmaceutical supplier to federal agencies, with extensive contracting activity spanning multiple therapeutic categories including oncology treatments, biologics, specialty pharmaceuticals, and medical consumables. The company's appointment as a regional prime vendor under the PPV-G GEN V program, which features a ceiling value of $499,999,999 and extends through December 31, 2036, reflects its competitive standing and proven performance delivering diverse and specialized pharmaceutical requirements to support military medical operations globally. This delivery order for Botox represents one of numerous fulfillments under the broader prime vendor contract framework that enables the DLA to maintain efficient, consistent access to essential pharmaceutical products across the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DB26FWUSC?
SPE2DB26FWUSC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FWUSC worth?
The government has obligated $25,874 on SPE2DB26FWUSC.
Is contract SPE2DB26FWUSC an order under another contract?
Yes. SPE2DB26FWUSC is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB26FWUSC competed?
The extent of competition for SPE2DB26FWUSC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award